Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide
Date
2012
Authors
Hsiao, M.H.
Larsson, M.
Larsson, A.
Evenbratt, H.
Chen, Y.Y.
Chen, Y.Y.
Liu, D.M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Controlled Release, 2012; 161(3):942-948
Statement of Responsibility
Conference Name
Abstract
Thermo-gelling injectable nanogels, with no burst release of loaded drug, were prepared by a simple route by combining self assembled nanocapsules of amphiphilically modified chitosan with glycerophosphate di-sodium salt and glycerol. The potential as a depot drug delivery system was demonstrated in vivo through the therapeutic effect of ethosuximide (ESM) loaded nanogels, suppressing spike wave discharges (SWDs) in Long Evan rat model. Simultaneously clearance of gels from the site of administration was monitored non-invasively using MRI.
The gel structure was characterized using TEM and SEM, confirming the gels to be an assembly of nanocapsules and using two-photon microscopy to visualize the network structure. In vitro drug release studies using ESM revealed that the nanogels exhibited extended, mostly Fickian release. Finally, all investigated formulations displayed excellent cytotoxicity data determined by MTT assay using human retinal pigmented epithelium cells. All presented properties are highly desirable for injectable depot gels for drug delivery.
School/Discipline
Dissertation Note
Provenance
Description
Link to a related website: http://publications.lib.chalmers.se/records/fulltext/158468/local_158468.pdf, Open Access via Unpaywall
Access Status
Rights
Copyright 2012 Elsevier